These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9234541)

  • 21. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
    Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
    Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
    Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.
    Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA
    Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
    Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
    Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid vectors as anti-viral vaccines.
    Ertl HC; Verma P; He Z; Xiang ZQ
    Ann N Y Acad Sci; 1995 Nov; 772():77-87. PubMed ID: 8546415
    [No Abstract]   [Full Text] [Related]  

  • 29. A single dose of recombinant adenoviral vector rabies vaccine expressing two copies of glycoprotein protects mice from lethal virus challenge.
    Li Q; He H; Zhou Y; Wang J; Chen H; Liu H
    J Infect Dev Ctries; 2024 Aug; 18(8):1281-1290. PubMed ID: 39288397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection.
    Lodmell DL; Sumner JW; Esposito JJ; Bellini WJ; Ewalt LC
    J Virol; 1991 Jun; 65(6):3400-5. PubMed ID: 2033678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep.
    DeMartini JC; Bickle HM; Brodie SJ; He BX; Esposito JJ
    Arch Virol; 1993; 133(1-2):211-22. PubMed ID: 8240013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies.
    Niu Y; Liu Y; Yang L; Qu H; Zhao J; Hu R; Li J; Liu W
    Virol Sin; 2016 Apr; 31(2):168-75. PubMed ID: 27068655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
    Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of rabies glycoprotein expressed in yeast.
    Klepfer SR; Debouck C; Uffelman J; Jacobs P; Bollen A; Jones EV
    Arch Virol; 1993; 128(3-4):269-86. PubMed ID: 8435044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
    Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z
    J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A thermostable messenger RNA based vaccine against rabies.
    Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
    Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants.
    Zhu JH; Wang J; Cai B; Zhao W; Zhu Y; Chao R; Chen L; Xue H; Ying BL; Li CP; Hu QL; Sha J; Esposito JJ
    Arch Virol; 1996; 141(6):1055-65. PubMed ID: 8712923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.